Skip to content

Clinical trials

Thrombosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombosis Country / region: United States Clear all

300 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20025
20036
20047
200511
200617
200713
200811
200914
201010
20116
201210
201311
201418
201513
201617
201719
201810
201916
202012
202112
20229
20239
20249
202514
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed201
Recruiting36
Terminated26
Unknown status18
Withdrawn11
Active, not recruiting6
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
HemoSonics LLC19
Bristol-Myers Squibb12
ARCA Biopharma, Inc.9
Brigham and Women's Hospital8
Wake Forest University Health Sciences5
Aronora, Inc.4
Icahn School of Medicine at Mount Sinai4
Johns Hopkins University4
Massachusetts General Hospital4
National Institutes of Health Clinical Center (CC)4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombosis300
Venous Thrombosis39
Hemorrhage30
Pulmonary Embolism27
Venous Thromboembolism26
Stroke22
Thromboembolism22
Inflammation18
Hemostatic Disorders15
Cardiovascular Diseases14

Trials

Showing 1 to 25 of 300. Each trial links to its page on Pharma Observatory.

200 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.